Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|9|2082-2089

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.9, 2015-09, pp. : 2082-2089

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG‐interferon

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 3, 2015-03 ,pp. : 318-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low HBeAg Serum Levels Correlate with the Presence of the Double A1762T/G1764A Core Promoter Mutation and a Positive Response to Interferon in Patients with Chronic Hepatitis B Virus Infection

By  

Intervirology, Vol. 46, Iss. 4, 2003-09 ,pp. : 222-226

Karger

Access to resources Recommend Favorite

IFNL4 rs368234815 and rs117648444 variants predict off‐treatment HBsAg seroclearance in IFN‐treated HBeAg‐negative chronic hepatitis B patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 3, 2018-03 ,pp. : 417-423

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis B Virus Genotype D Predominates HBsAg-Positive Egyptian Blood Donors and Is Mainly Associated with a Negative HBeAg Serostatus

By  

Intervirology, Vol. 56, Iss. 5, 2013-07 ,pp. : 278-283

Karger

Access to resources Recommend Favorite

Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen‐positive chronic hepatitis B

By  

HEPATOLOGY, Vol. 56, Iss. 1, 2012-07 ,pp. : 67-75

John Wiley & Sons Inc

Access to resources Recommend Favorite